Inducibility and reproducibility of ventricular arrhythmias: Therapeutic implications  by Gomes, J. Anthony
JACC Vol 7, No.4 
AprIl 1986:829-31 
Editorial Comment 
Inducibility and Reproducibility 
of Ventricular Arrhythmias: 
Therapeutic Implications* 
J. ANTHONY GOMES, MD, FACC 
New York, New York 
Electrophysiologic studies have gained wide acceptance in 
clinical cardiology, particularly for the diagnosis and man•
agement of patients with symptomatic ventricular tachy•
cardia and survivors of sudden cardiac arrest. Clinical stud•
ies have shown that the suppression of induced ventricular 
arrhythmias during serial electrophysiologic-pharmacologic 
testing is predictive of a favorable long-term outcome (1-3). 
In contrast, a high recurrence of arrhythmic events and poor 
long-term survival are noted in patients in whom antiar•
rhythmic agents do not prevent the induction of the tachy•
arrhythmia (4). Of equal importance, electrophysiologic 
studies, in addition to having considerably enhanced our 
knowledge of impulse formation and transmission, have 
been partly responsible for ushering in new therapeutic mo•
dalities that have already demonstrated a positive impact on 
the survival of high risk patients exposed to the specter of 
sudden arrhythmic death (5-7). 
Issues raised by evolutionary aspects of programmed 
electrical stimulation. Simultaneously, we have witnessed 
a mushrooming of new and so-called aggressive stimulation 
protocols for the induction of ventricular arrhythmias in the 
laboratory. Stimulation techniques have evolved from rel•
atively simple protocols using rapid pacing (8,9), to the 
introduction of up to two premature stimuli during one or 
two ventricular pacing drives, to aggressive protocols uti•
lizing up to four premature stimuli at two or more ventricular 
pacing drives at a current of 5 mA or more at two or more 
right ventricular sites, and occasionally in the left ventricle 
as well. These evolutionary aspects of programmed elec•
trical stimulation have been a source of confusion and crit•
icism. Although it is just to seek information in the name 
of knowledge and to counter with the words of John Milton, 
"Where there is much desire to learn, there of necessity 
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will be much arguing, much writing, many opinions, for 
opinions in good men is knowledge in the making," it is 
likewise important to acknowledge several issues that the 
evolutionary aspects of programmed electrical stimulation 
have raised. Some of these issues are: 1) What is an ac•
ceptable stimulation protocol? 2) What is the day to day 
reproducibility of the rate and configuration of induced ven•
tricular tachycardia using different protocols? 3) Should 
stimulation protocols be tailored to the specific patient group 
being studied? and 4) What is the significance of polymor•
phic forms of ventricular tachycardia and ventricular fibril•
lation induced with conventional versus aggressive stimu•
lation protocols? 
The answers to some of these questions are not readily 
available and are difficult to obtain for several reasons: I) 
Animal models of ventricular tachycardia vary substantially 
from clinical ventricular tachycardia, such that information 
obtained in the animal laboratory is not readily applicable 
to humans. 2) The mechanism (reentry versus triggered 
automaticity) and site of origin (endocardial versus intra•
mural or epicardial) of ventricular tachycardia may be dif•
ferent in patients with different disease entities. 3) In a given 
patient, there may be more than one site of origin of ven•
tricular tachycardia. Thus, both the clinical and the induced 
tachycardia may have different rates and configurational 
characteristics. 4) Different stimulation protocols may result 
in substantial alteration of conduction and refractory char•
acteristics of the arrhythmogenic substrate and the normal 
myocardium, resulting in changes in rate and configuration 
of ventricular tachycardia, which may in part be dependent 
on the exit site of the tachycardia. In addition, different 
stimulation protocols (for example, burst pacing versus pre•
mature stimulation) may result in hemodynamic and isch•
emic consequences that may also influence the electro•
physiologic characteristics of the arrhythmogenic substrate. 
5) There may be inherent differences in the electrophysio•
logic characteristics of the arrhythmogenic substrate in pa•
tients with monomorphic ventricular tachycardia compared 
with those whose tachycardia readily degenerates into ven•
tricular fibrillation. 6) Programmed electrical stimulation 
may be the best test currently available to alter the "dor•
mant" arrhythmogenic substrate, as the induction of ven•
tricular tachycardia is dependent on the creation of func•
tional delays in conduction, block and differential 
refractoriness, but these requisite conditions for the induc•
tion, maintenance and termination of a reentrant arrhythmia 
may only rarely occur spontaneously in an as yet poorly 
defined clinical milieu. 
Inducibility and reproducibility of ventricular ar•
rhythmias by programmed electrical stimulation. The 
inducibility of ventricular arrhythmias in the clinical elec•




which the stimulation protocol, the presenting arrhythmia 
and the underlying heart disease are of paramount impor•
tance. The chances of inducing ventricular tachycardia are 
very high in patients with recurrent monomorphic ventric•
ular tachycardia. With the use of two premature stimuli at 
two ventricular basic drives introduced in the right ventric•
ular apex, the incidence of ventricular tachycardia induction 
ranges from 88 to 91 % (10,11). The addition of a third 
extrastimulus to the pacing protocol can increase the rate 
by 12 to 24% (11-13). Stimulation in the right ventricular 
outflow tract and in the left ventricle has been shown to 
result in a further increase in the induction of ventricular 
tachycardia. Of patients presenting with sustained ventric•
ular tachycardia, approximately 89 to 97% (12,14) have 
inducible arrhythmias, compared with 61 to 81 % of patients 
who present with cardiac arrest (12,14). The induction of 
polymorphic forms of ventricular tachycardia and ventric•
ular fibrillation with aggressive modes of stimulation (third 
and fourth extrastimuli) may be a nonclinical response, as 
these forms of arrhythmia have been induced in some pa•
tients who do not have a history of clinical sustained ven•
tricular tachycardia or aborted sudden death (11). The clin•
ical significance of induction of polymorphic ventricular 
tachycardia and ventricular fibrillation with conventional 
pacing protocols is unclear at this time; however, it is prob•
ably an important finding in patients with documented sus•
tained ventricular tachycardia or out-of-hospital aborted 
sudden death. The induction of a monomorphic ventricular 
tachycardia is a highly specific finding. 
In this issue of the Journal, Kudenchuk et al. (15) report 
on their study of the inducibility and reproducibility of ven•
tricular arrhythmias in /14 patients. They found a stepwise, 
significant increase in inducibility of ventricular arrhythmias 
as the stimulation protocol was carried to more aggressive 
modes of stimulation, particularly with the use of three and 
four extrastimuli. They noted an induction rate of 10% for 
rapid ventricular pacing, 10% for a single premature stim•
ulus, 28% for two extrastimuli, 48% for three extrastimuli 
and 64% for four extrastimuli. These induction rates are 
substantially lower in comparison with those in previously 
reported series of patients with sustained ventricular tachy•
cardia and survivors of sudden death. The low sensitivity 
of programmed ventricular stimulation in the study of Ku•
denchuk et al. may have occurred for the following reasons: 
1) there was marked heterogeneity in the patient group with 
respect to disease entity, drug history, incidence of ven•
tricular fibrillation versus ventricular tachycardia and iso•
lated versus recurrent episodes of ventricular tachycardia; 
and 2) an extremely high proportion of their patients (74 
[65%] of 114) had been receiving class I agents for Lown 
class 1 to 4a arrhythmia at the time of the out-of-hospital 
arrhythmic event. It is likely that in most of these patients 
this event was causally related to the type I agents, which 
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underscores the potential pro-arrhythmic effects of the an•
tiarrhythmic agents for treatment of ventricular premature 
beats. A high proportion of these patients had no inducible 
arrhythmia by single and double extrastimuli when they 
were not receiving type I agents and this group probably 
contributed to the low inducibility rate with conventional 
stimulation protocols. Although the difference in induci•
bility decreased when three and four extrastimuli were used, 
no data are provided regarding polymorphism and ventric•
ular fibrillation in these patients. It is likely that the induced 
arrhythmia in some of these patients in response to an ag•
gressive stimulation protocol may have been a nonspecific 
response. In our laboratory (16), we induced ventricular 
arrhythmias in only 23% of patients with Lown class 4a 
arrhythmia with the use of up to two extrastimuli and burst 
pacing. Although our patients with class 4a arrhythmia are 
not comparable with those studied by Kudenchuk et al. (15), 
our observation of a good survival rate in the patients with 
noninducible arrhythmia suggests that noninducibility with 
conventional protocols may be of greater clinical relevance 
than inducibility with aggressive stimulation protocols. 
Utilizing a point score change of 3 or more, Kudenchuk 
et al. (15) noted that induced arrhythmias were more fre•
quently nonreproducible (7 to 27%) in rate or duration, or 
both, as the number of extrastimuli increased from one to 
four; however, the rate of nonreproducibility when three 
and four extrastimuli were used did not differ significantly 
from that when two extrastimuli were used. The authors are 
to be lauded for using the duration as well as the rate of 
induced ventricular arrhythmias in their reproducibility scor•
ing system, unlike the systems used in previous studies. 
The limitations of their study, however, include the follow•
ing: I) If a patient's score increased from 5 (rate of 100 to 
160/min) to a score of 7 (rate of 201 to 300/min) the ar•
rhythmia was considered reproducible; however, if the same 
patient's score increased to 8 (rate> 300/min or ventricular 
fibrillation) the arrhythmia was considered nonreproducible. 
In such a patient it is likely that a score of either 7 or 8 
would result in a hemodynamically unstable arrhythmia. 2) 
In 14% of the patients the arrhythmia was induced with 
stimulation in the outflow tract, whereas reproducibility studies 
in these patients were performed in the cardiac apex. These 
differences in methodology could have partly accounted for 
nonreproducibility. 3) Serum levels of lidocaine were mon•
itored in 22 patients during the first study and achieved 
therapeutic concentration in a high proportion (32%). Be•
cause lidocaine was not used during the second study, this 
could have partly influenced reproducibility. 4) The config•
uration of the induced arrhythmia was not clarified to de•
termine whether the nonreproducible arrhythmias fell in the 
category of polymorphic ventricular tachycardia and fibril•
lation. This may have been the case, as nonreproducibility 
was highest with the use of four extrastimuli. 
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Implications. Kudenchuk et al. (15) have reservations 
about drug studies based on a nonreproducibility rate of 17 
to 27% and therefore recommend two baseline studies. This 
recommendation is not currently acceptable, because the 
inducibility and reproducibility data provided by the authors 
apply only to the patient group they studied and to the 
protocol used in their laboratory. There is evidence to sug•
gest that replacement of the stimulation catheter improves 
reproducibility of arrhythmia induction (17). Furthermore, 
before their recommendation is accepted, it would perhaps 
be better to tailor the stimulation protocol to the patient 
group being studied and, in addition, to assess the config•
urational characteristics of the induced arrhythmia. Patients 
with documented sustained ventricular tachycardia and sur•
vivors of out-of-hospital aborted sudden death may be sub•
jected to a stepwise increase in stimulation protocol, as 
suggested by Kudenchuk et al. (15). However, this leaves 
the option of the introduction of "n number" of premature 
stimuli, which is to be discouraged at this time. 
An appropriate protocol in such patients seems to be the 
introduction of up to three premature stimuli at two paced 
cycle lengths at twice diastolic threshold at two right ven•
tricular sites (apex and outflow tract) and burst pacing. Uti•
lizing this protocol in our laboratory, ventricular tachycardia 
can be initiated in more than 90% of patients with docu•
mented recurrent sustained ventricular tachycardia and in 
70% of patients with aborted sudden death. The induction 
of monomorphic ventricular tachycardia does not need con•
firmation of reproducibility in two separate studies. The 
induction of a polymorphic ventricular tachycardia, partic•
ularly with a third extrastimulus, may need reproducibility 
studies. It is noteworthy that the number of electrocardio•
graphic leads recorded during electrophysiologic studies and 
during out-of-hospital events limits the assessment of con•
figuration in both spontaneously occurring and induced ar•
rhythmias. Ventricular fibrillation that results from a run of 
monomorphic ventricular tachycardia may be of clinical 
relevance in contrast to that resulting from a run of poly•
morphic tachycardia. Prospective studies are needed in a 
large number of patients to clarify this issue. In patients 
with noninducible arrhythmia with aborted sudden death, 
other causes such as ischemia, use of antiarrhythmic therapy 
and electrolyte imbalance should be carefully assessed and 
corrected. Whereas it is crucial to continue to seek knowl•
edge in this important area. it is time to critically review 
past experience regarding the role of electrophysiologic•
pharmacologic testing to establish the most appropriate pro•
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